The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 19 (1) , 9-15
- https://doi.org/10.1023/a:1013884426692
Abstract
Astrocytic tumors are the most common human brain tumors. Establishment of tumor grade is a key determinant both in the choice of a therapeutic approach and in the prognosis. The diagnosis of...Keywords
This publication has 35 references indexed in Scilit:
- Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumorsInternational Journal of Cancer, 2001
- Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude MiceJournal of Biological Chemistry, 2000
- Motility and invasion are differentially modulated by Rho family GTPasesOncogene, 2000
- Loss of Rho function in the thymus is accompanied by the development of thymic lymphomaOncogene, 2000
- Rho-like GTPasesEuropean Journal Of Cancer, 1999
- Reduction of Caveolin 1 Gene Expression in Lung Carcinoma Cell LinesBiochemical and Biophysical Research Communications, 1999
- Rho proteins induce metastatic properties in vivoOncogene, 1997
- Lack of prognostic relevance of alterations in the epidermal growth factor receptor—transforming growth factor-α pathway in human astrocytic gliomasJournal of Neurosurgery, 1996
- Expression of variant CD44 epitopes in human astrocytic brain tumorsJournal of Neuro-Oncology, 1995
- Caveolin Isoforms Differ in Their N-terminal Protein Sequence and Subcellular Distribution. IDENTIFICATION AND EPITOPE MAPPING OF AN ISOFORM-SPECIFIC MONOCLONAL ANTIBODY PROBEJournal of Biological Chemistry, 1995